Since the discovery that LPAR1 is overexpressed in samples from patients with idiopathic pulmonary fibrosis (IPF) and kidney fibrosis, several groups tried to target LPARs or ATX with small molecules to inhibit fibrosis. The gene discussed is LPAR1; the disease is pulmonary fibrosis.